Legal Representation
Attorney
Peter T. Wakiyama
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 18, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 17, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 13, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 11, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Jul 11, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Jan 15, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jan 11, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 11, 2019 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Jan 11, 2019 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Jan 11, 2019 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 11, 2018 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jul 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 11, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Jul 11, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 21, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 20, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Feb 20, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 5, 2018 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Feb 5, 2018 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Feb 5, 2018 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Feb 5, 2018 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jan 11, 2018 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 11, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 16, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 16, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 26, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 7, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 6, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 5, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 5, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 27, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 27, 2017 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 27, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 16, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 15, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 15, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 15, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 15, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 15, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 8, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 1, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 27, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical consulting services, namely, the retrieval, integration, correlation, analysis and interpretation of genomic, sequencing and molecular data, diseases, biomarkers, drug protocols, drug interactions, clinical profiles, and medical and health information, records or data, and patient specific data, molecular test results, data from clinical studies, and scientific research for medical diagnostic and treatment purposes; consulting services in the fields of medical care, pharmaceuticals and medicine; providing medical information in the fields of health, healthcare, life sciences, biotechnology, pharmaceuticals and pharmaceutical safety, bioinformatics, and genetic testing for medical purposes; medical consulting services with respect to the treatment and diagnosis of individuals; providing medical information on drug safety and drug compatibility in relation to therapy and the treatment of individuals; medical consulting services in the fields of diagnostics and patient treatment and treatment protocols
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MOLECULAR HEALTH"